Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

Introducing BIO INX: Innovative Biomaterials for Readily3D’s Volumetric 3D Printing Technology

Reading Time: < 1 minute

Bioink technology firm BIO INX has made a groundbreaking partnership with volumetric 3D printing company Readily3D to introduce new biomaterials for volumetric 3D bioprinting. The collaboration has resulted in the development of the first commercially available bioink, READYGEL INX gel-MA based ink, specifically designed for high reproducibility and exceptional performance in volumetric bioprinting applications.

Volumetric 3D printing is a cutting-edge technology capable of printing structures within seconds, revolutionizing the field of bioprinting. The READYGEL INX ink is delivered sterile and ready-to-use, following BIO INX’s “plug and print” principle to streamline the bioprinting process and provide researchers with unprecedented ease of use.

Coralie Gréant, COO at BIO INX, expressed excitement about the potential of the new technology, stating, “Thanks to the speed of this technology and the highly biocompatible resin, the futuristic idea of harvesting cells, printing directly alongside the patient in the operating room prior to reimplantation becomes an attainable reality.”

By leveraging tomographic 3D printing, which solidifies photosensitive inks in three dimensions using shaped light beams from multiple angles, centimeter-scale biological systems with microscale resolution can be produced in seconds. CEO of BIO INX, Jasper Van Hoorick, emphasized the importance of standardization and reproducibility in bioprinting technology, highlighting the significant advancements made through volumetric bioprinting.

Paul Delrot, CEO of Readily3D, emphasized the commitment to delivering comprehensive solutions to customers by partnering with BIO INX to provide high-reproducibility bioinks for clinical applications of bioprinting. The collaboration between these two innovative companies marks a significant step forward in the field of bioprinting and brings the vision of bringing bioprinting technology to clinics within the next decade closer to reality.

Taylor Swifts New Album Release Health issues from using ACs Boston Marathon 2024 15 Practical Ways To Save Money